NO306700B1 - Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister - Google Patents

Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Info

Publication number
NO306700B1
NO306700B1 NO944214A NO944214A NO306700B1 NO 306700 B1 NO306700 B1 NO 306700B1 NO 944214 A NO944214 A NO 944214A NO 944214 A NO944214 A NO 944214A NO 306700 B1 NO306700 B1 NO 306700B1
Authority
NO
Norway
Prior art keywords
pct
rectal administration
alkylsulfonamides
agonists
pharmaceuticals
Prior art date
Application number
NO944214A
Other languages
English (en)
Norwegian (no)
Other versions
NO944214L (no
NO944214D0 (no
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of NO944214D0 publication Critical patent/NO944214D0/no
Publication of NO944214L publication Critical patent/NO944214L/no
Publication of NO306700B1 publication Critical patent/NO306700B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO944214A 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister NO306700B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (3)

Publication Number Publication Date
NO944214D0 NO944214D0 (no) 1994-11-04
NO944214L NO944214L (no) 1994-11-07
NO306700B1 true NO306700B1 (no) 1999-12-13

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944214A NO306700B1 (no) 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Country Status (33)

Country Link
US (1) US5705506A (pt)
EP (1) EP0639072B1 (pt)
JP (1) JPH07506570A (pt)
KR (1) KR100253111B1 (pt)
AT (1) ATE163850T1 (pt)
AU (1) AU670083B2 (pt)
BE (1) BE1007024A5 (pt)
BG (1) BG62120B1 (pt)
BR (1) BR1100108A (pt)
CA (1) CA2135179C (pt)
CH (1) CH685920A5 (pt)
CY (1) CY2039B1 (pt)
CZ (1) CZ283512B6 (pt)
DE (1) DE69317418T2 (pt)
ES (1) ES2113533T3 (pt)
FR (1) FR2690847B1 (pt)
GB (2) GB9209882D0 (pt)
GR (1) GR3026584T3 (pt)
HK (1) HK95697A (pt)
HU (2) HU227338B1 (pt)
IE (1) IE75203B1 (pt)
IL (1) IL105468A (pt)
IT (1) IT1261471B (pt)
NO (1) NO306700B1 (pt)
NZ (1) NZ252132A (pt)
OA (1) OA10109A (pt)
RO (1) RO112993B1 (pt)
RU (1) RU2118527C1 (pt)
SG (1) SG46649A1 (pt)
TW (1) TW231970B (pt)
UA (1) UA37206C2 (pt)
WO (1) WO1993021916A1 (pt)
ZA (1) ZA933178B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
RU2214244C9 (ru) * 1998-03-26 2020-07-29 Астеллас Фарма Инк. Препараты с замедленным высвобождением
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
EP3090743A1 (en) 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
WO2012048710A1 (en) 2010-10-15 2012-04-19 Concit Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
RU2670272C2 (ru) 2012-04-18 2018-10-22 Контера Фарма Апс Пероральная фармацевтическая композиция, подходящая для повышения эффективности лечения двигательных нарушений
WO2017152130A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8103764A (nl) * 1980-08-12 1982-03-01 Glaxo Group Ltd Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4785016A (en) * 1984-12-04 1988-11-15 Glaxo Group Limited Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
US4997841A (en) * 1987-08-13 1991-03-05 Glaxo Group Limited Indole derivatives
AU646871B2 (en) * 1990-06-07 1994-03-10 Astrazeneca Uk Limited Therapeutic heterocyclic compounds

Also Published As

Publication number Publication date
GR3026584T3 (en) 1998-07-31
RO112993B1 (ro) 1998-03-30
BR1100108A (pt) 1999-12-07
ZA933178B (en) 1994-01-10
IL105468A (en) 1998-09-24
ITRM930286A1 (it) 1994-11-06
HU227338B1 (en) 2011-04-28
DE69317418D1 (de) 1998-04-16
GB2266665B (en) 1996-05-22
IT1261471B (it) 1996-05-23
IE930339A1 (en) 1993-11-17
TW231970B (pt) 1994-10-11
HK95697A (en) 1997-08-08
HU211638A9 (en) 1995-12-28
US5705506A (en) 1998-01-06
NZ252132A (en) 1996-09-25
SG46649A1 (en) 1998-02-20
BG62120B1 (bg) 1999-03-31
BG99167A (bg) 1995-06-30
NO944214L (no) 1994-11-07
EP0639072A1 (en) 1995-02-22
OA10109A (en) 1996-12-18
GB9209882D0 (en) 1992-06-24
IL105468A0 (en) 1993-08-18
GB9309209D0 (en) 1993-06-16
ES2113533T3 (es) 1998-05-01
CH685920A5 (fr) 1995-11-15
DE69317418T2 (de) 1998-07-30
NO944214D0 (no) 1994-11-04
CZ283512B6 (cs) 1998-04-15
CY2039B1 (en) 1998-04-30
UA37206C2 (uk) 2001-05-15
JPH07506570A (ja) 1995-07-20
ATE163850T1 (de) 1998-03-15
RU2118527C1 (ru) 1998-09-10
ITRM930286A0 (it) 1993-05-06
FR2690847A1 (fr) 1993-11-12
GB2266665A (en) 1993-11-10
AU4064093A (en) 1993-11-29
AU670083B2 (en) 1996-07-04
WO1993021916A1 (en) 1993-11-11
BE1007024A5 (fr) 1995-02-21
IE75203B1 (en) 1997-08-27
CZ272394A3 (en) 1995-10-18
EP0639072B1 (en) 1998-03-11
FR2690847B1 (fr) 1995-06-09
CA2135179C (en) 2000-12-05
KR100253111B1 (en) 2000-07-01
CA2135179A1 (en) 1993-11-11
HUT71418A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
ATE331726T1 (de) Adenine-derivate
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
NO20061737L (no) Aminosubstituerte erylamino B2 adrenergiske receptoragonister
ITRM920155A0 (it) Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, e relativo procedimento di preparazione e trattamento con essa di mammiferi.
NO951613L (no) Ikke-peptidyl tachykinin reseptorantagonister
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
AR024138A1 (es) Inhibidores de la proliferacion celular
NO306700B1 (no) Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister
ES2147758T3 (es) Preparacion sinergistica para la activacion de celulas destructoras naturales.
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
SE9702002D0 (sv) Novel compounds
NO995685D0 (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
DE59303446D1 (de) Neue bis-phenyl-hexene
ECSP972347A (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
ECSP972049A (es) Derivados de lactama
AR011169A1 (es) Compuestos derivados de quinoxalinadionas, su uso para la preparacion de medicamentos, compuestos intermediarios y procedimiento para preparar dichos medicamentos

Legal Events

Date Code Title Description
MK1K Patent expired